Viewing Study NCT03644459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2026-02-22 @ 5:23 PM
Study NCT ID: NCT03644459
Status: WITHDRAWN
Last Update Posted: 2020-03-11
First Post: 2018-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
Sponsor: Lynkcell Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Cervical Cancer View
None Colorectal Cancer View
None Stomach Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None autocrine loops View
None LYN00101 View
None Tolerability View
None Safety View
None Humanized Anti-VEGF Monoclonal Antibody View